Cargando…

Therapeutic Drug Monitoring of Etoposide in a 14‐Day Infusion for Non‐small‐cell Lung Cancer

We investigated whether a constant plasma concentration could be obtained by the individualized administration of low‐dose, prolonged‐infusional etoposide. Etoposide was infused for 14 days at 40 mg/m(2)day initially in patients with inoperable non‐small‐cell lung cancer. The infusion rate was modif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ando, Yuichi, Minami, Hironobu, Saka, Hideo, Ando, Masahiko, Sakai, Shuzo, Shimokata, Kaoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1996
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921058/ https://www.ncbi.nlm.nih.gov/pubmed/8609070 http://dx.doi.org/10.1111/j.1349-7006.1996.tb03159.x

Ejemplares similares

Therapeutic Drug Monitoring in 21‐Day Oral Etoposide Treatment for Lung Cancer
por: Ando, Yuichi, et al.
Publicado: (1996)

Pharmacokinetic Study of Carboplatin Given on a 5‐Day Intravenous Schedule
por: Ando, Yuichi, et al.
Publicado: (1997)

Prognostic Factors for Short‐term Survival in Patients with Stage IV Non‐small Cell Lung Cancer
por: Ando, Masahiko, et al.
Publicado: (1999)

Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.
por: Ando, Y., et al.
Publicado: (1997)

Genetic Polymorphisms of the UDP‐Glucuronosyltransferase 1A7 Gene and Irinotecan Toxicity in Japanese Cancer Patients
por: Ando, Maki, et al.
Publicado: (2002)

Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
por: Ando, M, et al.
Publicado: (2001)

Stability of Etoposide Solutions in Disposable Infusion Devices for Day Hospital Cancer Practices
por: Klasen, Alison, et al.
Publicado: (2014)

Establishment and Characterization of Resistant Cells to Etoposide (VP16) from a Mouse Breast Cancer Cell Line, FM3A
por: Takagi, Eishi, et al.
Publicado: (1988)

Continuous-infusion verapamil with etoposide in relapsed or resistant paediatric cancers.
por: Cowie, F. J., et al.
Publicado: (1995)

CARBOPLATIN DOSING FOR ADULT JAPANESE PATIENTS
por: ANDO, YUICHI, et al.
Publicado: (2014)

Etoposide Protects Mice from Radiation‐induced Bone Marrow Death
por: Yamada, Sigeru, et al.
Publicado: (1990)

Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab
por: Kamitani, Rei, et al.
Publicado: (2022)

Clinical pharmacokinetics of etoposide during 120 hours continuous infusions in solid tumours.
por: Desoize, B., et al.
Publicado: (1990)

Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies
por: Minami, Hironobu, et al.
Publicado: (2020)

Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide
por: Kanno, Toshiyuki, et al.
Publicado: (2018)

Improving Bisphosphonate Infusion Monitoring at Haematology Medical Day Unit
por: Ong, Michal Wen Sheue, et al.
Publicado: (2017)

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
por: de Jong, R. S., et al.
Publicado: (1997)

Impact of dexamethasone, etoposide, ifosfamide and carboplatin as concurrent chemoradiotherapy agents for nasal natural killer/T-cell lymphoma
por: HATAYAMA, YOSHIOMI, et al.
Publicado: (2013)

A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.
por: Anderson, H., et al.
Publicado: (1993)

Dietary Supplement Use by Community-living Population in Japan: Data from the National Institute for Longevity Sciences Longitudinal Study of Aging (NILS-LSA)
por: Imai, Tomoko, et al.
Publicado: (2006)

Infusion of etoposide in the CA1 disrupts hippocampal immediate early gene expression and hippocampus-dependent learning
por: Boutros, Sydney Weber, et al.
Publicado: (2022)

Impact of indoor temperature instability on diurnal and day-by-day variability of home blood pressure in winter: a nationwide Smart Wellness Housing survey in Japan
por: Umishio, Wataru, et al.
Publicado: (2021)

Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
por: de Jong, R. S., et al.
Publicado: (1997)

Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implants
por: Wu, Chunsheng, et al.
Publicado: (2020)

Chemotherapy for biliary tract cancer: real-world experience in a single institute
por: Maeda, Osamu, et al.
Publicado: (2020)

Correction to: Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021)

Vitiligo and tumor response in a patient with amelanotic melanoma undergoing nivolumab treatment
por: Furune, Satoshi, et al.
Publicado: (2021)

Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel
por: Minami, Hironobu, et al.
Publicado: (2001)

Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
por: Siderov, J, et al.
Publicado: (2002)

Transition of Historical Control Data for High Incidence Tumors in F344 Rats
por: Kuroiwa, Yuichi, et al.
Publicado: (2013)

Hearing impairment risk and interaction of folate metabolism related gene polymorphisms in an aging study
por: Uchida, Yasue, et al.
Publicado: (2011)

Divergent Significance of Bone Mineral Density Changes in Aging Depending on Sites and Sex Revealed through Separate Analyses of Bone Mineral Content and Area
por: Matsui, Yasumoto, et al.
Publicado: (2012)

The impact of anthropometric and ocular parameters on optic cup-to-disc ratio
por: Fukuoka, Hideki, et al.
Publicado: (2017)

Guidelines for clinical evaluation of anti‐cancer drugs
por: Minami, Hironobu, et al.
Publicado: (2021)

Molecular mechanisms of etoposide
por: Montecucco, Alessandra, et al.
Publicado: (2015)

Association of Day-to-Day Variations in Physical Activity with Postprandial Appetite Regulation in Lean Young Males
por: Ando, Takafumi, et al.
Publicado: (2019)

A Phase I/II Study of a 72-h Continuous Infusion of Etoposide in Advanced Soft Tissue Sarcoma
por: Crawley, Charles R., et al.
Publicado: (1997)

A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer.
por: Ando, M., et al.
Publicado: (1998)

Phase I study of alpelisib (BYL719), an α‐specific PI3K inhibitor, in Japanese patients with advanced solid tumors
por: Ando, Yuichi, et al.
Publicado: (2019)

Men who were thin during early adulthood exhibited greater weight gain‐associated visceral fat accumulation in a study of middle‐aged Japanese men
por: Koda, M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_51sfccvu70st3t6t0il58fbq2v